✦ LIBER ✦

Phase I study of oxaliplatin in patients with advanced cancer

✍ Scribed by Jean Marc Extra; Marc Espie; Fabien Calvo; Christophe Ferme; Laurent Mignot; Michel Marty

Publisher: Springer
Year: 1990
Tongue: English
Weight: 480 KB
Volume: 25
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00684890

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oxaliplatin plus raltitrexed in patients

Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma : Results of a Phase I–II trial

✍ Werner Scheithauer; Gabriela V. Kornek; Herbert Ulrich-Pur; Melitta Penz; Markus 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

Gemcitabine plus oxaliplatin (GEMOX) in

Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC) : Results of a phase II study

✍ Samy Louafi; Valérie Boige; Michel Ducreux; Luminita Bonyhay; Touraj Mansourbakh 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

A Phase I trial of weekly lomustine in p

A Phase I trial of weekly lomustine in patients with advanced cancer

✍ Charles A. Koller; Carolyn C. Gorski; Robert S. Benjamin; Sewa S. Legha; Nichola 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB 👁 2 views

Nonspecific immunotherapy by corynebacte

Nonspecific immunotherapy by corynebacterium Parvum. Phase I toxicity study in 12 patients with advanced cancer

✍ Vincent S. T. Cheng; Herman D. Suit; C. C. Wang; Charles Cummings 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 636 KB

Phase 2 trial of oxaliplatin plus capeci

Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer

✍ Henry Q. Xiong; Gauri R. Varadhachary; Joan C. Blais; Kenneth R. Hess; James L. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

Phase I trial of extracellular adenosine

Phase I trial of extracellular adenosine 5′-triphosphate in patients with advanced cancer

✍ Haskell, Charles M.; Wong, Maylene; Williams, Adrian; Lee, Le-Young 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 883 KB

Adenosine 5'-triphosphate (ATP) has antineoplastic activity in vitro and in murine tumor systems, but there are no data in humans defining its potential use as an antineoplastic agent. We conducted a Phase I study to determine the spectrum of toxicity, maximum safely tolerated dose (MTD), and pharma